Home | Log In | Register | Our Services | My Account | Contact | Help |
Intraday
4 month candkestick with Indicators ad support /resistance
6 month Bollinger Bands,RSI, S Stochastic and 50 days MA
Charts - 5 days
Links batm web Vigilant Web PLUS Market Trades
Dr Zvi Marom, Chief Executive of BATM said:
"The year ended 31 December 2009 has demonstrated the resilience of BATM's
technologies and business model. Despite challenging market conditions, BATM has
achieved modest revenue growth and strong cash flow whilst continuing to invest
in technologies and sales channels to strengthen our market position. BATM has
successfully established its medical division during 2009 and we expect this
division to grow substantially over the coming years.
"We continue to implement our strategic plan in 2010 of investing in
technologies and sales channels: we are seeing a high level of customer activity
in our direct channels (in particular in the US) and expansion of indirect sales
channels should also help to grow overall revenues. We believe that 2010 will
bring to fruition a number of exciting projects including innovative product
releases across all our business lines.
"Accordingly, despite the continuing uncertainty in the global telecoms market
that will result in a higher sales mix of the medical division during 2010, we
have begun the year with a healthy pipeline and remain cautiously optimistic for
the coming year."
Chairman's Statement
I am pleased to report on a year which has delivered record revenues despite
challenging market conditions and seen the strengthening of BATM's business in
every aspect. During 2009 BATM has released market leading cellular backhauling
technology, broadened its Medical division and focused on reducing its cost base
and strengthening its cash flow. Working capital management has been improved
with $66.8 million of liquid investments at the year end (2008: $57.3 million).
BATM has used its strong cash position to acquire real estate at opportunistic
prices in the U.S and Israel which will replace rented properties currently used
by BATM in the course of 2010 and 2011. The Company also intends to utilise
some of its accumulated cash at the year end to distribute a significantly
increased final dividend.
During the year the Company maintained its long held policy of working with
minimum risk customers and short credit terms.
On the basis of these results, the Board is in a position to recommend the
payment of a final dividend of 1.35 pence per share (2008: 0.69 pence), which
includes a special payment of 0.55 pence per share as a return to shareholders
of the excess cash generated by the business.
Financial Performance
Revenues grew modestly in 2009, despite difficult market conditions, to reach a
new high of $135.4 million (2008: $134.5 million). There was a significant
underlying change in sales mix with Telecom sales totalling $105.7m (2008:
$116.1m) mainly as a result of lower revenues in a challenging US market, and
Medical sales totalling $29.7m (2008: $18.4m).
The gross profit margin has decreased to 42.6% (2008: 45.6%) primarily due to
this change in the sales mix. In comparison to H2 2008 the gross profit margin
has increased from 41.4% due to slight increases in profitability both in the
Telecoms and Medical sectors. In the Telecoms sector this is primarily due to
favourable Euro - US dollar exchange rates in the last part of 2009, whilst in
the Medical sector this is primarily due to efficiency programs.
Total sales and marketing expenses were $13.6 million (2008: $13.9 million), a
decrease of 2.2% on the previous year. We have succeeded in reducing these
costs by increasing the proportion of revenues through indirect sales channels
with existing customers, which typically incur lower direct expense, and
optimisation programmes. As a percentage of revenue, sales and marketing
expenses were 10.0% (2008: 10.0%).
General and administrative expenses were $9.4 million (2008: $8.4 million)
representing 6.9% of revenue, compared with 6.2% in 2008. This increase is
primarily related to the effects of full year operations for the new medical
sector businesses. We continue our integration of these new businesses into our
group structure in order to reduce this overhead.
R&D expenses in 2009 were $11.8 million (2008: $12.8 million), a decrease of
7.8%. The decrease is largely a result of the depreciation of the Israeli Shekel
against the US dollar, but also reflects our increased R&D in new fields offset
by efficiency programmes in BATM's traditional R&D units.
Operating profit was $16.4million (2008: $23.6 million) after amortization of
intangible assets totalling $4.0 million (2008: $2.6 million), which has
increased due to our acquisitions both in 2009 and 2008, and certain one-off
exceptional items. Other operating expenses therefore include a one-off
write-down of the leases and leasehold improvements in two US properties of $1.2
million, following a strategic decision to relocate to a purchased property in
Foxboro, and an impairment of $1.3 million of goodwill in relation to Vigilant.
Adjusted operating profit, adding back these items, was $23.0 million (2008:
$26.2 million).
Net finance income was $2.0 million (2008: $0.1 million). This figure primarily
consists of $2.6 million of interest income, as well as $1.3 million of gains on
forward contracts and debt forgiveness, which has been offset by $1.5 million of
foreign exchange losses.
Net profit after tax attributable to equity holders of the parent amounted to
$20.5 million (2008: $24.2 million), resulting in a basic profit per share of
5.11c (2008: 6.19c)
Our balance sheet remains strong with effective liquidity of $66.8 million
(2008: $57.3 million). This is after a dividend payment of $4.6 million, and an
investment of $13.5million in fixed assets (see below).
Intangible assets have increased to $23.3 million (2008: $18.9 million), and
Goodwill has increased to $11.3million (2008: $9.4 million). This increase is
primarily due to the purchase of ISE and other businesses, offset by
amortisation of intangibles and goodwill impairment totalling $5.3 million.
Property, plant and equipment has increased by $11.8 million from 31 December
2008 to $21.9 million as at 31 December 2009. During the year BATM took
advantage of low real estate prices to purchase two offices located in Foxboro,
Massachusetts and Hod Hasharon, Israel. These investments cost a total of
$9.7million.
Total liabilities have increased by $14.7million from 31 December 2008 to $46.3
million as at 31 December 2009. This increase is primarily due to $6.7 million
of liabilities assumed on the acquisition of ISE, and $4.5 million mortgage
drawn for the purchase of the building in Hod Hasharon, Israel.
Sales and Marketing
During 2009 we have focused on strengthening and expanding our indirect sales
channels. We have succeeded in increasing these channels and believe that this
will help us grow our revenues in 2010. In our direct sales channels, customer
activity is very high, in particular in the US.
Research and Development and New Products
Over the past year we have developed a new generation of cellular back-haul
Ethernet products. These switches contain cutting edge technology to facilitate
linking cellular masts to provider networks, including extremely accurate time
synchronisation. These products provide solutions to the new infrastructure
required to support the ever increasing number of IP enabled smart phones.
In 2010 we have an aggressive development programme for increasing our network
management platform to upgrade it into a very high end servicing platform. We
believe that these platforms will become increasingly important in the future as
the services supplied over service providers' networks grow and become
increasingly sophisticated. Over the course of the year we will release a
complete solution including a 40G platform.
BATM Medical
During the course of 2009, BATM continued its strategic investments into the
Medical sector. In December 2009, BATM purchased the intellectual property and
certain assets of a clinical chemistry and immunology diagnostics company for
approximately EUR2 million. The operations of the business were purchased from
bankruptcy proceedings and are based mainly in Italy. We expect these assets to
significantly strengthen the product range and know how in the Group's current
operations in the clinical chemistry field.
Towards the end of 2009 the BATM Medical Group showcased two new innovative
products, the Miura One, a niche clinical chemistry analyser for small
laboratories, and the Integrated Shredder Steriliser ("ISS"). The ISS is a
machine that dramatically reduces the environmental impact and cost associated
with the disposal of medical waste. Orders have been received for both products
and BATM is gearing up production in 2010.
During 2010 we expect to continue our cost reduction program in the Medical
Division in order to increase the gross profit margin, realise synergies across
the division and begin to see revenues from OEM agreements signed over the past
year in this sector.
Investments
During the first quarter of 2009 BATM strengthened its local presence in the
Telecoms business in Israel by purchasing the trade and assets of a local
company and integrating it into our existing local structure.
Our strategic investments during the year included the investment in the medical
segment described above, as well as the acquisition of a controlling interest in
ISE in February 2009 as previously reported.
Dividend
The Board is of the opinion that, in light of the Company's profitability, it
should continue its dividend distribution policy. Accordingly, it has proposed,
subject to shareholder consent, a final dividend for 2009 of 1.35 pence per
share (2009: 0.69p), which includes a special payment of 0.55 pence per share as
a return to shareholders of the excess cash generated by the business. In making
this decision the Board has carefully considered the likely future capital
requirements of the business and believes that the Company should have fully
adequate cash resources to meet these requirements. The Board does not envisage
recommending an interim dividend in the coming year.
Prospects
Despite the continuing uncertainty in the global economy we have begun 2010 with
a healthy pipeline of business across the Group. In the coming year BATM should
begin to benefit from the impact of the release of our complete solution in the
telecoms sector, replacing declining business in some of our legacy product
lines. In the medical sector we believe that we will see significant growth from
new channels and synergies. Accordingly we remain cautiously optimistic for the
coming year.
Peter Sheldon
Chairman
08 February 2010
+--------------------------------------+----------------+-----------+
| | Year ended 31 |
| | December |
+--------------------------------------+----------------------------+
| | 2009 | 2008 |
+--------------------------------------+----------------+-----------+
| | US$ in thousands |
+--------------------------------------+----------------------------+
| | |
+--------------------------------------+----------------------------+
| Revenues | 135,395 | 134,462 |
+--------------------------------------+----------------+-----------+
| | | |
+--------------------------------------+----------------+-----------+
| Cost of revenues | 77,671 | 73,157 |
+--------------------------------------+----------------+-----------+
| | | |
+--------------------------------------+----------------+-----------+
| Gross profit | 57,724 | 61,305 |
+--------------------------------------+----------------+-----------+
| | --------- | --------- |
+--------------------------------------+----------------+-----------+
| Operating expenses | | |
+--------------------------------------+----------------+-----------+
| | | |
+--------------------------------------+----------------+-----------+
| Sales and marketing expenses | 13,591 | 13,948 |
+--------------------------------------+----------------+-----------+
| | | |
+--------------------------------------+----------------+-----------+
| General and administrative | 9,407 | 8,376 |
| expenses | | |
+--------------------------------------+----------------+-----------+
| | | |
+--------------------------------------+----------------+-----------+
| Research and development expenses | 11,763 | 12,829 |
+--------------------------------------+----------------+-----------+
| | | |
+--------------------------------------+----------------+-----------+
| Other operating expenses | 6,529 | 2,597 |
+--------------------------------------+----------------+-----------+
| | | |
+--------------------------------------+----------------+-----------+
| Total operating expenses | 41,290 | 37,750 |
+--------------------------------------+----------------+-----------+
| | --------- | --------- |
+--------------------------------------+----------------+-----------+
| Operating profit | 16,434 | 23,555 |
+--------------------------------------+----------------+-----------+
| | | |
+--------------------------------------+----------------+-----------+
| Investment revenue | 2,562 | 2,453 |
+--------------------------------------+----------------+-----------+
| Gains (losses) on financial | 1,260 | (4,340) |
| instruments | | |
+--------------------------------------+----------------+-----------+
| Foreign exchange differences | (1,452) | 2,512 |
+--------------------------------------+----------------+-----------+
| Finance cost | (356) | (480) |
+--------------------------------------+----------------+-----------+
| | | |
+--------------------------------------+----------------+-----------+
| Profit before tax | 18,448 | 23,700 |
+--------------------------------------+----------------+-----------+
| | | |
+--------------------------------------+----------------+-----------+
| Tax benefit | 867 | 454 |
+--------------------------------------+----------------+-----------+
| | | |
+--------------------------------------+----------------+-----------+
| Profit for the year | 19,315 | 24,154 |
+--------------------------------------+----------------+-----------+
| | | |
+--------------------------------------+----------------+-----------+
| Attributable to: | | |
+--------------------------------------+----------------+-----------+
| Owners of the Company | 20,517 | 24,205 |
+--------------------------------------+----------------+-----------+
| Non-controlling interests | (1,202) | (51) |
+--------------------------------------+----------------+-----------+
| | | |
+--------------------------------------+----------------+-----------+
| Income for the year | 19,315 | 24,154 |
+--------------------------------------+----------------+-----------+
| | | |
+--------------------------------------+----------------+-----------+
| Earnings per share (in cents) basic | 5.11 | 6.19 |
+--------------------------------------+----------------+-----------+
| Earnings per share (in cents) | 5.08 | 6.15 |
| diluted | | |
+--------------------------------------+----------------+-----------+
+--------------------------------------+----------------+-------------+
| | Year ended 31 |
| | December |
+--------------------------------------+------------------------------+
| | 2009 | 2008 |
+--------------------------------------+----------------+-------------+
| | US$ in thousands |
+--------------------------------------+------------------------------+
| | Unaudited | Unaudited |
+--------------------------------------+----------------+-------------+
| | | |
+--------------------------------------+----------------+-------------+
| Profit for the year | 19,315 | 24,154 |
+--------------------------------------+----------------+-------------+
| Exchange differences on translating | 2,669 | (6,111) |
| foreign operations | | |
+--------------------------------------+----------------+-------------+
| Total Comprehensive Income of the | 21,984 | 18,043 |
| year | | |
+--------------------------------------+----------------+-------------+
| Attributable to: | | |
+--------------------------------------+----------------+-------------+
| Owners of the Company | 22,562 | 18,220 |
+--------------------------------------+----------------+-------------+
| Non-controlling interest | (578) | (177) |
+--------------------------------------+----------------+-------------+
BATM ADVANCED COMMUNICATIONS LTD.
CONSOLIDATED BALANCE SHEETS
+---------------------------------------+------------------+-----------------+
| | 31 December | 31 December |
+---------------------------------------+------------------+-----------------+
| | 2 0 0 9 | 2 0 0 8 |
+---------------------------------------+------------------+-----------------+
| | US$ in thousands |
+---------------------------------------+------------------------------------+
| | | |
+---------------------------------------+------------------+-----------------+
| Non-current assets | | |
+---------------------------------------+------------------+-----------------+
| | | |
| Goodwill | 11,345 | 9,418 |
+---------------------------------------+------------------+-----------------+
| Other intangible assets | 23,323 | 18,937 |
| Property, plant and equipment | 21,911 | 10,041 |
| Held to maturity investments | 4,347 | 5,468 |
| Deferred tax assets | 4,848 | 3,531 |
+---------------------------------------+------------------+-----------------+
| | 65,774 | 47,395 |
+---------------------------------------+------------------+-----------------+
| | | |
+---------------------------------------+------------------+-----------------+
| Current assets | | |
+---------------------------------------+------------------+-----------------+
| Inventories | 22,040 | 20,984 |
+---------------------------------------+------------------+-----------------+
| Investments | 34,332 | 21,086 |
+---------------------------------------+------------------+-----------------+
| Trade and other receivables | 31,171 | 29,192 |
+---------------------------------------+------------------+-----------------+
| Cash and cash equivalents | 28,095 | 30,737 |
+---------------------------------------+------------------+-----------------+
| | 115,638 | 101,999 |
+---------------------------------------+------------------+-----------------+
| | | |
+---------------------------------------+------------------+-----------------+
| Total assets | 181,412 | 149,394 |
+---------------------------------------+------------------+-----------------+
| | | |
| Current liabilities | | |
| Short-term bank credit | 6,139 | 3,632 |
| Trade and other payables | 21,624 | 20,283 |
| Provisions | 3,505 | 2,181 |
| | 31,268 | 26,096 |
+---------------------------------------+------------------+-----------------+
| Net current assets | 84,370 | 75,903 |
+---------------------------------------+------------------+-----------------+
| | | |
+---------------------------------------+------------------+-----------------+
| Non-current liabilities | | |
| Long-term liabilities | 14,219 | 4,599 |
+---------------------------------------+------------------+-----------------+
| Retirement benefit obligation | 875 | 926 |
| | 15,094 | 5,525 |
| | ______ | ______ |
| Total liabilities | 46,362 | 31,621 |
| | | |
+---------------------------------------+------------------+-----------------+
| Net assets | 135,050 | 117,773 |
+---------------------------------------+------------------+-----------------+
| | | |
+---------------------------------------+------------------+-----------------+
| Equity | | |
+---------------------------------------+------------------+-----------------+
| Share capital | 1,214 | 1,210 |
+---------------------------------------+------------------+-----------------+
| Share premium account | 405,961 | 404,928 |
+---------------------------------------+------------------+-----------------+
| Foreign currency translation reserve | (3,229) | (6,060) |
| and other reserves | | |
+---------------------------------------+------------------+-----------------+
| Accumulated Deficit | (270,808) | (286,764) |
+---------------------------------------+------------------+-----------------+
| Equity attributable to: | | |
+---------------------------------------+------------------+-----------------+
| Owners of the Company | 133,138 | 113,314 |
+---------------------------------------+------------------+-----------------+
| Non-controlling interest | 1,912 | 4,459 |
+---------------------------------------+------------------+-----------------+
| Total equity | 135,050 | 117,773 |
+---------------------------------------+------------------+-----------------+
BATM ADVANCED COMMUNICATIONS LTD.
CONSOLIDATED STATEMENT OF CASH FLOWS
+----------------------------------------+-------------+--------------+
| | Year ended 31 December |
+----------------------------------------+----------------------------+
| | | |
+----------------------------------------+-------------+--------------+
| | 2 0 0 9 | 2 0 0 8 |
+----------------------------------------+-------------+--------------+
| | |
+----------------------------------------+----------------------------+
| | US$ in thousands |
+----------------------------------------+----------------------------+
| | | |
+----------------------------------------+-------------+--------------+
| | | |
+----------------------------------------+-------------+--------------+
| | | |
+----------------------------------------+-------------+--------------+
| Net cash from operating activities | 20,234 | 9,094 |
| (Appendix A) | | |
+----------------------------------------+-------------+--------------+
| | ---------- | ---------- |
+----------------------------------------+-------------+--------------+
| Investing activities | | |
+----------------------------------------+-------------+--------------+
| | | |
| Interest received | 1,461 | 1,363 |
| Proceeds on disposal of held to | 3,233 | 1,472 |
| maturity investments | | |
| Proceeds on disposal of financial | 18,433 | 13,608 |
| assets carried at fair value through | 30,453 | 17,908 |
| profit and loss | | |
| Proceeds on disposal of deposits | | |
+----------------------------------------+-------------+--------------+
| Purchases of property, plant and | (13,583) | (1,154) |
| equipment | 61 | - |
| Proceeds on disposal of property, | (361) | - |
| plant and equipment | (2,967) | - |
| Purchases of intangible assets | - | (1,050) |
| Purchases of activity | | |
| Purchases of held to maturity | (15,450) | (21,574) |
| investments | (47,335) | (14,000) |
| Purchases of financial assets carried | | |
| at fair value through profit and loss | | |
| Purchases of deposits | | |
+----------------------------------------+-------------+--------------+
| Investment in a company | - | (280) |
+----------------------------------------+-------------+--------------+
| Acquisition of subsidiaries (Appendix | 132 | (7,239) |
| B) | | |
+----------------------------------------+-------------+--------------+
| Net cash used in investing activities | (25,923) | (10,946) |
+----------------------------------------+-------------+--------------+
| | ---------- | ---------- |
+----------------------------------------+-------------+--------------+
| Financing activities | | |
+----------------------------------------+-------------+--------------+
| | | |
+----------------------------------------+-------------+--------------+
| Dividend payment | (4,561) | (3,936) |
+----------------------------------------+-------------+--------------+
| Increase (decrease) in short-term bank | 1,468 | (1,549) |
| credit | | |
+----------------------------------------+-------------+--------------+
| Bank loan received | 3,000 | - |
+----------------------------------------+-------------+--------------+
| Bank loan repayment | (59) | - |
+----------------------------------------+-------------+--------------+
| Proceeds on issue of shares | 378 | 3,515 |
+----------------------------------------+-------------+--------------+
| Net cash from (used in) financing | 226 | (1,970) |
| activities | | |
+----------------------------------------+-------------+--------------+
| | ---------- | ----------- |
+----------------------------------------+-------------+--------------+
| | | |
+----------------------------------------+-------------+--------------+
| Decrease in cash and cash equivalents | (5,463) | (3,822) |
+----------------------------------------+-------------+--------------+
| | | |
+----------------------------------------+-------------+--------------+
| Cash and cash equivalents at the | | |
| beginning of the year | 30,737 | 35,809 |
+----------------------------------------+-------------+--------------+
| | | |
+----------------------------------------+-------------+--------------+
| Effects of exchange rate changes on | | |
| the balance of cash held in foreign | 2,821 | (1,250) |
| currencies | | |
+----------------------------------------+-------------+--------------+
| Cash and cash equivalents at the end | 28,095 | 30,737 |
| of the year | | |
+----------------------------------------+-------------+--------------+
| | | |
+----------------------------------------+-------------+--------------+
BATM ADVANCED COMMUNICATIONS LTD.
APPENDICES TO CONSOLIDATED STATEMENT OF CASH FLOWS
APPENDIX A
RECONCILIATION OF OPERATING PROFIT FOR THE PERIOD TO NET CASH
FROM OPERATING ACTIVITIES
+----------------------------------------------+----------+-----------+
| | Year ended 31 |
| | December |
+----------------------------------------------+----------------------+
| | 2 0 0 9 | 2 0 0 8 |
+----------------------------------------------+----------+-----------+
| | US$ in thousands |
+----------------------------------------------+----------------------+
| | | |
+----------------------------------------------+----------+-----------+
| Operating profit from continuing operations | 16,434 | 23,555 |
| Adjustments for: | | |
+----------------------------------------------+----------+-----------+
| Amortization of intangible assets and | 5,355 | 2,597 |
| goodwill | | |
+----------------------------------------------+----------+-----------+
| Depreciation of property, plant and | 2,865 | 2,401 |
| equipment | | |
+----------------------------------------------+----------+-----------+
| Stock options granted to employees | 659 | 791 |
+----------------------------------------------+----------+-----------+
| Increase (decrease) in retirement benefit | (65) | 154 |
| obligation | | |
+----------------------------------------------+----------+-----------+
| Increase (decrease) in provisions | 575 | (313) |
| | | |
+----------------------------------------------+----------+-----------+
| Operating cash flow before movements in | 25,823 | 29,185 |
| working capital | | |
+----------------------------------------------+----------+-----------+
| Increase in Inventory | (310) | (4,080) |
+----------------------------------------------+----------+-----------+
| Decrease (increase) in receivables | (2,186) | 3,965 |
+----------------------------------------------+----------+-----------+
| Decrease in payables | (3,180) | (18,709) |
+----------------------------------------------+----------+-----------+
| Cash generated by operations | 20,147 | 10,361 |
+----------------------------------------------+----------+-----------+
| Income tax paid | (173) | (844) |
| | | |
+----------------------------------------------+----------+-----------+
| Income tax received | 557 | - |
| | | |
+----------------------------------------------+----------+-----------+
| Interest paid | (297) | (423) |
+----------------------------------------------+----------+-----------+
| Net cash from operating activities | 20,234 | 9,094 |
+----------------------------------------------+----------+-----------+
APPENDIX B
ACQUISITION OF SUBSIDIARIES
+----------------------------------------------+---------+----------+
| | Year ended 31 |
| | December |
+----------------------------------------------+--------------------+
| |2 0 0 9 | 2 0 0 8 |
+----------------------------------------------+---------+----------+
| | US$ in thousands |
+----------------------------------------------+--------------------+
| | | |
+----------------------------------------------+---------+----------+
| Net assets acquired | | |
+----------------------------------------------+---------+----------+
| Property, plant and equipment | 1,432 | 2,727 |
+----------------------------------------------+---------+----------+
| Inventory | 205 | 4,436 |
+----------------------------------------------+---------+----------+
| Trade and other receivables | 446 | 6,008 |
+----------------------------------------------+---------+----------+
| Trade and other payables | (2,387) | (14,310) |
| Short-term bank credit | (2,823) | (5,091) |
| Retirement benefit obligation | - | (437) |
| Long term payables | (3,044) | (1,117) |
+----------------------------------------------+---------+----------+
| Provisions | - | (178) |
+----------------------------------------------+---------+----------+
| Non controlling interest | 1,183 | (3,678) |
+----------------------------------------------+---------+----------+
| | (4,988) | (11,640) |
+----------------------------------------------+---------+----------+
| Goodwill | 1,231 | 11,519 |
+----------------------------------------------+---------+----------+
| Intangible assets | 3,625 | 9,772 |
+----------------------------------------------+---------+----------+
| Total consideration | (132) | 9,651 |
+----------------------------------------------+---------+----------+
| Less-consideration recorded as liability | - | (2,412) |
+----------------------------------------------+---------+----------+
| Total cash consideration | (132) | 7,239 |
+----------------------------------------------+---------+----------+
BATM ADVANCED COMMUNICATIONS LTD
CONSOLIDATED STATEMENTS OF CHANGE IN EQUITY
+-----------------+---------+---------+-------------+----------+-------------+--------------+-------------+---------+
| | | Share | | | |Attributable | | |
| | Share |Premium |Translation | Other |Accumulated |to owners of | Non- | Total |
| |capital |Account | reserve |reserves | Deficit | the parent |controlling | equity |
| | | | | | | | interest | |
+-----------------+---------+---------+-------------+----------+-------------+--------------+-------------+---------+
| | US $ in thousands |
+-----------------+-------------------------------------------------------------------------------------------------+
| | | | | | | | | |
| As at | | | | | | | | |
| 1 January | 1,186 | 400,646 | (29) | - | (307,033) | 94,770 | 958 | 95,728 |
| 2008 | | | | | | | | |
+-----------------+---------+---------+-------------+----------+-------------+--------------+-------------+---------+
| | | | | | | | | |
+-----------------+---------+---------+-------------+----------+-------------+--------------+-------------+---------+
| Exercise of | | | | | | | | |
| share based | 20 | 2,583 | | | | 2,603 | - | 2,603 |
| options by | | | | | | | | |
| employees | | | | | | | | |
+-----------------+---------+---------+-------------+----------+-------------+--------------+-------------+---------+
| Recognition | | | | | | | | |
| of | | 791 | | | | 791 | - | 791 |
| share-based | | | | | | | | |
| payments | | | | | | | | |
+-----------------+---------+---------+-------------+----------+-------------+--------------+-------------+---------+
| Share based | | | | | | | | |
| purchase of | 4 | 908 | | | | 912 | - | 912 |
| Vigilant | | | | | | | | |
+-----------------+---------+---------+-------------+----------+-------------+--------------+-------------+---------+
| Purchase of | | | | | | | | |
| non- | | | (46) | | | (46) | - | (46) |
| controlling | | | | | | | | |
| interest | | | | | | | | |
+-----------------+---------+---------+-------------+----------+-------------+--------------+-------------+---------+
| Non-controlling | | | | | | | | |
| interest | | | | | | - | 3,678 | 3,678 |
| acquired | | | | | | | | |
+-----------------+---------+---------+-------------+----------+-------------+--------------+-------------+---------+
| | | | | | | | | |
| Dividend | | | | | (3,936) | (3,936) | - | (3,936) |
+-----------------+---------+---------+-------------+----------+-------------+--------------+-------------+---------+
| Other | | | | | | | | |
| comprehensive | | | (5,985) | | 24,205 | 18,220 | (177) | 18,043 |
| income | - | - | | - | | | | |
+-----------------+---------+---------+-------------+----------+-------------+--------------+-------------+---------+
| | | | | | | | | |
+-----------------+---------+---------+-------------+----------+-------------+--------------+-------------+---------+
| As at 31 | | | | | | | | |
| December 2008 | | | | | | | | |
| | 1,210 | 404,928 | (6,060) | - | (286,764) | 113,314 | 4,459 | 117,773 |
+-----------------+---------+---------+-------------+----------+-------------+--------------+-------------+---------+
| | | | | | | | | |
+-----------------+---------+---------+-------------+----------+-------------+--------------+-------------+---------+
| Exercise of | | | | | | | | |
| share based | | | | | | | | |
| options by | 4 | 374 | | | | 378 | - | 378 |
| employees | | | | | | | | |
+-----------------+---------+---------+-------------+----------+-------------+--------------+-------------+---------+
| Recognition | | | | | | | | |
| of | | 659 | | | | 659 | - | 659 |
| share-based | | | | | | | | |
| payments | | | | | | | | |
+-----------------+---------+---------+-------------+----------+-------------+--------------+-------------+---------+
| Purchase of | | | | | | | | |
| non- | | | | | | - | (1,183) | (1,183) |
| controlling | | | | | | | | |
| interest | | | | | | | | |
+-----------------+---------+---------+-------------+----------+-------------+--------------+-------------+---------+
| Non-controlling | | | | | | | | |
| interest | | | | 786 | | 786 | (786) | - |
| acquired | | | | | | | | |
+-----------------+---------+---------+-------------+----------+-------------+--------------+-------------+---------+
| | | | | | | | | |
| Dividend | | | | | (4,561) | (4,561) | - | (4,561) |
+-----------------+---------+---------+-------------+----------+-------------+--------------+-------------+---------+
| Other | | | | | | | | |
| comprehensive | - | - | 2,045 | - | 20,517 | 22,562 | (578) | 21,984 |
| income | | | | | | | | |
+-----------------+---------+---------+-------------+----------+-------------+--------------+-------------+---------+
| | | | | | | | | |
| As at 31 | | | | | | | | |
| December 2009 | 1,214 | 405,961 | (4,015) | 786 | (270,808) | 133,138 | 1,912 | 135,050 |
| | | | | | | | | |
+-----------------+---------+---------+-------------+----------+-------------+--------------+-------------+---------+
BATM ADVANCED COMMUNICATIONS LTD
NOTES TO THE FINANCIAL STATEMENTS
Note 1 - General
The preliminary results for the year ended 31 December 2009 and the comparative
2008 information are presented in accordance with International Financial
Reporting Standards ("IFRS").
Note 2 - Profit per share
Earning per share is based on the weighted average number of shares in issue for
the year of 401,579,099 (2008: 396,222,088). The number used for the calculation
of the diluted earning per share for the year (which includes the effect of
dilutive stock option plans) is 403,939,818 shares (2008: 398,679,591).
Note 3 - Business Segment
+--------------+-------------------------+----------+----------+
| Year ended 31 December 2 0 0 9 |
+--------------------------------------------------------------+
| | | | |
| | Telecommunications | | Total |
| | | Medical | |
+--------------+-------------------------+----------+----------+
| US$ in thousands |
+--------------------------------------------------------------+
| | | | |
+--------------+-------------------------+----------+----------+
| Revenues | 105,702 | 29,693 | 135,395 |
+--------------+-------------------------+----------+----------+
| | | | |
+--------------+-------------------------+----------+----------+
| Operating | 24,664 | (1,701) | 22,963 |
| profit | | | |
| (loss), | | | |
| before other | | | |
| operating | | | |
| expenses | | | |
+--------------+-------------------------+----------+----------+
| | | | |
+--------------+-------------------------+----------+----------+
| Assets | 144,553 | 36,859 | 181,412 |
+--------------+-------------------------+----------+----------+
| | | | |
+--------------+-------------------------+----------+----------+
| Year ended 31 December 2 0 0 8 |
+--------------------------------------------------------------+
| | | | |
| | Telecommunications | | Total |
| | | Medical | |
+--------------+-------------------------+----------+----------+
| US$ in thousands |
+--------------------------------------------------------------+
| | | | |
+--------------+-------------------------+----------+----------+
| Revenues | 116,053 | 18,409 | 134,462 |
+--------------+-------------------------+----------+----------+
| | | | |
+--------------+-------------------------+----------+----------+
| Operating | 25,600 | 552 | 26,152 |
| profit, | | | |
| before other | | | |
| operating | | | |
| expenses | | | |
+--------------+-------------------------+----------+----------+
| | | | |
+--------------+-------------------------+----------+----------+
| Assets | 124,728 | 24,666 | 149,394 |
+--------------+-------------------------+----------+----------+